Additionally, lung tumor-derived cDC1s express lower levels of T cell immunoglobulin mucin-4 (TIM4), leading to decreased tumor-associated antigen uptake and lower activation of CD8+ cells in advanced stages of murine lung tumors (Caronni et al., 2021). The gene discussed is CD8A; the disease is neoplasm.